FOCAL CORTICAL DYSPLASIA

Clinical trials for FOCAL CORTICAL DYSPLASIA explained in plain language.

Never miss a new study

Get alerted when new FOCAL CORTICAL DYSPLASIA trials appear

Sign up with your email to follow new studies for FOCAL CORTICAL DYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

New hope for Hard-to-Treat seizures: experimental drug radiprodil enters human testing

Symptom relief Ongoing

This study tests an experimental drug called radiprodil in 30 people with tuberous sclerosis complex (TSC) or focal cortical dysplasia (FCD) type II whose seizures have not improved with at least two other medications. The main goals are to check the drug's safety and how the bod…

Matched conditions: FOCAL CORTICAL DYSPLASIA

Phase: PHASE1, PHASE2 • Sponsor: GRIN Therapeutics, Inc. • Aim: Symptom relief

Last updated May 17, 2026 10:04 UTC

FOCAL CORTICAL DYSPLASIA

Get alerted when new FOCAL CORTICAL DYSPLASIA trials appear

New hope for Hard-to-Treat seizures: experimental drug radiprodil enters human testing